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Background: Young-onset colorectal cancer is uncommon, but the incidence is increasing. Despite several guidelines for colonoscopic 
surveillance following colorectal cancer resection, there is little consistency regarding the timing and age-adjusted strategies of surveillance 
colonoscopy after surgery of young-onset colorectal cancer. The aim of this study was to compare the outcomes of surveillance colonoscopy 
between sporadic colorectal cancer patients with young and older age after curative resection.
Methods: We retrospectively reviewed 569 colorectal cancer patients who underwent curative resection between January 2006 and 
December 2010. The primary outcome was comparison of the development of metachronous advanced neoplasia during surveillance 
colonoscopy between young and older colorectal cancer patients.
Results: There were 95 patients in the young age group and 474 patients in the older age group. The mean time interval from surgery 
to the development of metachronous advanced neoplasia was 99.2 ± 3.7 months in the young age group and 84.4 ± 2.5 months 
in the old age group (P = 0.03). In the multivariate analysis, age (OR, 3.56; P = 0.04) and family history of colorectal cancer (OR, 
2.66; P = 0.008) were associated with the development of metachronous advanced neoplasia. None of the young patients without 
both family history of colorectal cancer and high-risk findings at index colonoscopy showed advanced neoplasia during the follow-up 
period.
Conclusions: Age and family history of colorectal cancer are independent risk factors for the occurrence of advanced neoplasia after 
curative colorectal cancer resection, suggesting age-adjusted strategies of surveillance colonoscopy.
(J Cancer Prev 2017;22:1 59 -165)
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INTRODUCTION
Colorectal cancer (CRC) is the third most common cancer and 
a significant cause of cancer-related death.1 It is well known that 
the incidence of CRC increases with age, and most patients are 
diagnosed at over 50 years of age.1-3 However, a recent 
epidemiologic study showed that over the past few decades, the 
incidence of CRC has continuously increased in the younger 
population, aged under 50 years, in contrast to a slight decline in 
patients older than 50 years.4 Despite the rising incidence, the 
clinicopathological features and prognosis of young-onset CRC 
remain controversial.5,6
Colonoscopic surveillance after curative resection of CRC is 
important to prevent the development of metachronous CRC in 
the remnant colon and rectum.7,8 Current National Comprehensive 
Cancer Network (NCCN) and the USA Multi-Society Task Force 
guidelines suggest colonoscopic surveillance within 1 year after 
curative resection of CRC in patients who underwent complete 
colonoscopy prior to surgery and within 3 to 6 months in those 
with incomplete preoperative colonoscopy due to obstruction. 
The subsequent follow-up interval is determined according to the 
findings of the first follow-up surveillance including the size, 
number, and pathologic features of adenomas. If the colonoscopy 
result is negative for any adenomatous or serrated polyps, the 
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second surveillance colonoscopy is recommended after 3 years.7,9 
Current colonoscopic surveillance guidelines after CRC 
surgery do not consider age, despite the fact that age is a 
significant factor in the development of adenomatous polyps or 
advanced neoplasia.10 NCCN guidelines mention that more 
frequent colonoscopies may be indicated in patients who present 
with colon cancer before 50 years of age.9 However, there has 
been insufficient evidence to support the need for a more 
intensive colonoscopy strategy in young patients without 
inherited syndromes, such as Lynch syndrome, familial adeno-
matous polyposis, and inflammatory bowel disease (IBD). For this 
reason, heterogeneous follow-up strategies continue to be 
pursued in colonoscopic surveillance following curative resection. 
Therefore, we compared surveillance colonoscopic outcomes 
between the young and the older CRC patients after curative 
resection and investigated independent factors associated with 
the development of metachronous advanced neoplasia to 




Between January 2006 and December 2010, a total of 795 
patients fulfilling the following criteria were initially included in 
this retrospective review: (1) curative surgical resection due to 
CRC; (2) available index colonoscopy records; and (3) available 
records from more than one follow-up surveillance colonoscopy 
at Severance Hospital in Korea. Patients meeting the following 
criteria were excluded: (1) stage 4 CRC or palliative resection (n = 
3); (2) total colectomy or transanal excision (n = 2); (3) hereditary 
CRC (n = 11); (4) IBD (n = 1); (5) history of another malignancy (n 
= 27); (6) first follow-up colonoscopy performed more than 2 
years after curative resection for CRC (n = 171); and (7) follow-up 
period of less than 1 year after surgery (n = 3). Following the 
exclusion of 226 patients based on our exclusion criteria, a total of 
569 patients were finally reviewed. Surveillance colonoscopy 
records were collected up to three times after surgery during 
follow-up periods.
This study was approved by the Institutional Review Board 
(IRB) of Severance Hospital, Yonsei University in Seoul, Korea (IRB 
No. 4-2015-1170). 
2. Definition
Young-onset was defined as age under 50 years at the time of 
diagnosis.6,9,11 Tumor staging was performed according to the 
American Joint Commission on Cancer standards contem-
poraneous to the treatment period. Body mass index (BMI) was 
categorized as follows: underweight (BMI ＜ 18.5 kg/m2), normal 
weight (BMI 18.5-22.9 kg/m2), overweight (BMI 23.0-24.9 kg/m2), 
and obese (BMI ＞ 25.0 kg/m2). Family history of CRC was defined 
as prior diagnosis of CRC in first-degree relatives. 
Index colonoscopy was defined as a recent complete colo-
noscopy with satisfactory preparation prior to surveillance colo-
noscopy, including postoperative colonoscopy within 6 months 
in patients who were unable to undergo preoperative complete 
colonoscopy due to obstruction.12 Tumor location was categorized 
under right colon (cecum, ascending colon), transverse colon, left 
colon (descending colon, sigmoid colon), or rectum. 
Advanced adenoma was defined as an adenoma with (1) villous 
histology features, (2) a size larger than 10 mm, (3) high-grade 
dysplasia, and (4) of the serrated sessile type. Advanced neoplasia 
was defined as adenocarcinoma including intramucosal carci-
noma and advanced adenoma. The high-risk patient group was 
considered to include patients with (1) advanced neoplasia and 
(2) more than three adenomas. The low-risk patient group was 
defined as the patients without high-risk findings. Metachronous 
advanced neoplasia did not include anastomosis site recurrence 
or locoregional recurrence.10,13
3. Primary and secondary outcomes
The primary outcome was comparison of the development of 
metachronous advanced neoplasia during surveillance colo-
noscopic between young and older patients. The secondary 
outcome was evaluation of risk factors for postoperative meta-
chronous advanced neoplasia development. 
4. Statistical analysis
Data are expressed as the median (interquartile range), 
number, or number (%), as appropriate. Factors associated with 
metachronous adenoma and advanced neoplasia were investi-
gated using the Cox regression. Any variables identified as signi-
ficant (P ＜ 0.05) in the univariate analysis were included in the 
multivariate analysis. 
For comparison of the cumulative probability of metachronous 
lesions, Kaplan-Meier estimator survival analysis was used; the 
recurrence curves of each group were compared by using a 
log-rank test. For comparing outcomes, the chi-square test or 
Fisher’s exact test was used for categorical data, and the Student’s 
t-test was used for continuous variables. Data analysis was 
performed using PASW software ver. 18.0 (IBM Co., Armonk, NY, 
USA). A two-sided P ＜ 0.05 was considered statistically significant.
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Young age (n = 95) Older age (n = 474)
Age at surgery (yr) 43.7 (28.0-49.0) 63.3 (50.0-85.0) 0.001
Sex (male：female) 51 (53.7)：44 (46.3) 309 (65.2)：165 (34.8) 0.03
Family history of colorectal cancer 11 (11.6) 42 (8.9) 0.40
Body mass index (kg/m2) 　 　 0.19
Below weight (＜ 18.5) 4 (4.2) 9 (1.9) 　
Normal (18.5-22.9) 45 (47.4) 185 (39.0) 　
Overweight (23.0-24.9) 22 (23.2) 130 (27.4) 　
Obese (＞ 25.0) 24 (25.3) 150 (31.7) 　
Alcohol 54 (56.8) 235 (49.6) 0.20
Smoking 38 (40.0) 184 (38.8) 0.83
Index colonoscopy finding 　 　 　
Adenoma positive patient 31 (32.6) 269 (56.8) 0.001
Advanced neoplasiab positive patient 19 (20.0) 147 (31.0) 0.03
Adenoma size (mm) (max) 13.0 ± 13.4 10.3 ± 7.9 0.09
High-risk patientc 20 (21.1) 175 (36.9) 0.003
Location of tumor 　 　 0.37
Right colon (cecum, ascending colon) 20 (21.1) 113 (23.8) 　
Transverse colon 5 (5.3) 23 (4.9) 　
Left colon (descending colon, sigmoid colon) 33 (34.7) 195 (41.1) 　
Rectum 37 (38.9) 142 (30.0) 　
AJCC stage 　 　 0.08
I 28 (29.5) 154 (32.5) 　
II 28 (29.5) 180 (38.0) 　
III 39 (41.1) 140 (29.5) 　
Differentiation 　 　 0.03
Well 25 (26.3) 110 (23.2) 　
Moderate 60 (63.2) 346 (73.0) 　
Poor 5 (5.3) 10 (2.1) 　
Mucinous 5 (5.3) 8 (1.7) 　
Lymphovascular invasion 29 (30.5) 94 (19.8) 0.02
CEA (ng/mL) 4.6 ± 8.4 4.5 ± 9.3 0.96
Values are presented as median (range), number (%), or mean ± SD. The sum of the percentages does not equal 100% because of rounding. 
AJCC, American Joint Committee on Cancer; CEA, carcinoembryonic antigen. aAge group defined as young age (＜ 50 years) and older age 
(≥ 50 years). bThis was defined as adenoma with (1) villous histology feature, (2) size larger than 10 mm, (3) high-grade dysplasia, (4) serrated 
sessile type, and (5) adenocarcinoma. cThese were defined as patients with advanced neoplasia or adenoma numbers more than three. 
RESULTS
1. Baseline characteristics
Baseline characteristics of the 569 patients are shown in 
Table 1. The median age at the time of surgery was 43.7 years 
(28.0-49.0 years) in the young age patients, compared to 63.3 years 
(50.0-85.0 years) in the older age patients (P = 0.001). In the older 
age group, a male predominance (65.2%) was revealed compared 
to the young age group (53.7%; P = 0.03). The proportion of 
patients with a family history of CRC was 11.6% in the young age 
group and 8.9% in the older age group, with no statistically 
significant difference. The index colonoscopy findings including 
existence of synchronous adenoma and advanced neoplasia is 
more common in old age group significantly (P = 0.001; P = 0.03). 
In this context, high-risk patients were more common in the 
older age group (P = 0.003). The young age group showed a high 
proportion of poor differentiation, mucinous histology (5.3%), 
and lymphovascular invasion (30.5%) in the resected specimens 
(P = 0.03; P = 0.02). BMI, alcohol history, smoking history, 
location of tumor, pathologic tumor stage, and preoperative 
carcinoembryonic antigen titer were not significantly different 
between the age groups.
2. Surveillance colonoscopy outcomes
During the follow-up period, surveillance colonoscopy was 
performed once in 158 patients (27.8%), twice in 312 patients 
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Table 2. Comparison of total number and interval of follow-up co-







No. of follow-up colonoscopy 　 0.18
1 21 (22.1) 137 (28.9) 　
2 52 (54.7) 260 (54.9) 　
3 22 (23.2) 77 (16.2) 　
Interval to follow-up colonoscopy 　 　
First (mo) 14.0 (12.0-15.0) 13.0 (12.0-16.0) 0.70
Second (mo) 35.0 (29.0-37.0) 34.0 (26.0-37.0) 0.22
Third (mo) 26.5 (15.7-35.8) 29.0 (19.0-37.0) 0.73
Values are presented as number (%) or median (interquartile range). 
aAge group defined as young age (＜ 50 years) and older age (≥
50 years).




Young age (n = 95) Older age (n = 474)
First surveillance colonoscopy (95：474)b 　
Adenoma positive patient 8 (8.4) 137 (28.9) 0.001
Advanced neoplasiac positive patient 1 (1.1) 16 (3.4) 0.33
Polyp size (max) (mm) 5.0 ± 2.2 5.9 ± 3.2 0.44
High-riskd patient 1 (1.1) 35 (7.4) 0.02
Second surveillance colonoscopy (74：337)b 　
Adenoma positive patient 9 (12.2) 107 (31.9) 0.001
Advanced neoplasicc positive patient 1 (1.4) 17 (5.1) 0.22
Polyp size (max) (mm) 4.1 ± 2.5 5.8 ± 5.0 0.32
High-riskd patient 2 (2.7) 26 (7.7) 0.13
Third surveillance colonoscopy (22：77)b 　
Adenoma positive patient 4 (18.2) 37 (48.1) 0.01
Advanced neoplasiac positive patient 1 (4.5) 6 (7.8) 0.69
Polyp size (max) (mm) 10.8 ± 12.9 5.7 ± 3.0 0.49
High-riskd patient 1 (4.5) 12 (15.6) 0.29
Total surveillance colonoscopy (95：474)b 　 　 　
Adenoma positive patient 16 (16.8) 209 (44.1) 0.001
Advanced neoplasiac positive patient 3 (3.2) 39 (8.2) 0.09
No. of advanced neoplasiac 0.03 ± 0.18 0.09 ± 0.30 0.02
High-riskd patient 4 (4.2) 68 (14.3) 0.007
Values are presented as number (%) or mean ± SD. aAge group defined as young age (＜ 50 years) and older age (≥ 50 years). bSubtotal 
of young age group：older age group. cThis was defined as adenoma with (1) villous histology features, (2) size larger than 10 mm, (3) 
high-grade dysplasia, (4) serrated sessile type, and (5) adenocarcinoma. dThese were defined as patients with advanced neoplasia or adenoma 
numbers more than three.
(54.8%), and three times in 99 patients (17.4%). The median time 
interval from the surgery to the first surveillance colonoscopy 
was 13.0 months. The mean periods of time from the first 
colonoscopy examinations to the second and the second to the 
third were 34.0 months and 28.0 months, respectively. There 
were no significant differences in the surveillance colonoscopy 
numbers and intervals between the young and older age groups 
(Table 2).
During follow-up surveillance colonoscopy, the metachronous 
adenoma positive rate was 16.8% in the young age group and 
44.1% in the older age group (P = 0.001). The proportion of 
high-risk patients and number of advanced neoplasia were also 
higher in the older age group (P = 0.007 and 0.02). However, there 
were no significant differences in the positive rate of meta-
chronous advanced neoplasia between the age groups (P = 0.09) 
(Table 3). 
3. Factors associated with metachronous advanced 
neoplasia
Cancer-related factors; patient-related factors including age, 
sex, BMI, alcohol history, smoking history, and family history of 
CRC; and index colonoscopy results, such as the existence of 
synchronous adenoma or advanced neoplasia, size and number 
of adenomas, and high-risk findings were analyzed to determine 
independent factors associated with the development of meta-
chronous advanced neoplasia. Among the factors, age (P = 0.03), 
family history of CRC (P = 0.01), and high-risk findings on index 
colonoscopy (P = 0.03) were found to be associated with the 
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Figure 1. Cumulative probability of metachronous advanced neo-
plasia during follow-up surveillance colonoscopy. Comparisons of 
metachronous advanced neoplasia between patients aged under 50 
years (n = 95) and over 50 years (n = 474).
Table 4. Univariate and multivariate analysis for the factors asso-
ciated with metachronous advanced neoplasia
Variable
Univariate Multivariate 
P-value P-value OR (95% CI)
Patient factor 　 　 　
Age groupa (young vs. 
older age)
0.03 0.04 3.56 (1.08-11.74)
Family history 0.01 0.008 2.66 (1.29-5.48)
Sex 0.29 　 　
Body mass index 0.11 　 　
Alcohol 0.44 　 　
Smoking 0.42 　 　
Cancer factor 　 　 　
Location 0.06 　 　
Stage 0.50 　 　
Differentiation 0.65 　 　
Lymphovascular invasion 0.06 　 　
Preoperative CEA 0.92 　 　
Polyp factor 　 　 　
Adenoma 0.07 　 　
Advanced neoplasia 0.05 　 　
Size (max) 0.24 　 　
Number 0.21 　 　
High-risk group 0.03 0.09 1.71 (0.91-3.19)
CEA, carcinoembryonic antigen. aAge group defined as young age 
(＜ 50 years) and older age (≥ 50 years). 
development of metachronous advanced neoplasia in univariate 
analysis. The mean time interval from surgery to the develop-
ment of metachronous advanced neoplasia was 99.2 ± 3.7 
months in the young age group and 84.4 ± 2.5 months in the old 
age group. Figure 1 shows the rate of development of meta-
chronous advanced neoplasia between the young and older age 
groups with Kaplan-Meier survival analysis. Subsequently, 
multivariate Cox regression analysis, including age group, family 
history of CRC, and high-risk group, revealed older age (P = 0.04; 
OR, 3.56; 95% CI, 1.08-11.74) and family history of CRC (P = 0.008; 
OR, 2.66; 95% CI, 1.29-5.48) as the independent risk factors 
associated with metachronous advanced neoplasia (Table 4). 
4. Outcomes according to risk factors
To identify young patients with a lower risk of metachronous 
advanced neoplasia in the surveillance colonoscopy, patients 
were divided into those with either a family history of CRC within 
first-degree relatives or high-risk index colonoscopic findings and 
those meeting neither of these two criteria. We identified 89 
patients (15.6%) in the former group and 480 patients (84.4%) in 
the latter group. The mean time interval from surgery to the 
development of metachronous advanced neoplasia in each of the 
groups was 71.4 ± 4.3 months and 94.5 ± 3.4 months, res-
pectively (P = 0.001). With further classification according to the 
age at diagnosis, 82 patients (86.3%) were categorized as young 
patients without a family history of CRC or high-risk features in 
the index colonoscopy. None of these patients had developed 
metachronous advanced neoplasia within 161 colonoscopic 
examinations during follow-up over a mean time period of 44.5 ± 
21.5 months.
DISCUSSION
The number of cases of young-onset CRC has been steadily 
increasing worldwide. Several studies have suggested that these 
patients may be characterized by more advanced stage disease 
and a higher incidence of poorly differentiated pathology, as well 
as a high proportion of hereditary CRC and IBD, compared to 
older CRC patients.5,11,14 The definition of young-onset CRC is still 
the subject of debate, and the cutoff age varies, ranging from 30 to 
50 years. In this study, we used 50 years as the cutoff age because 
most guidelines recommend screening colonoscopy in 
average-risk patients at the age of 50 years, and NCCN guidelines 
also mention that more frequent colonoscopy may be indicated in 
patients who present with CRC before that age.9,11
It is well known that one of the primary benefits of survei-
llance colonoscopy after curative resection for CRC is the 
detection of metachronous advanced neoplasia.15 Indeed, 
patients with hereditary CRC or IBD require a more frequent and 
intensive surveillance strategy, but there is a lack of evidence 
regarding the timing of the surveillance colonoscopy and 
whether more frequent colonoscopic surveillance is needed in 
young-onset CRC patients without risk factors such as hereditary 
CRC or IBD after curative resection in real life.16-18 To solve this 
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problem, we focused on comparison of the development of 
metachronous advanced neoplasia during surveillance colono-
scopy between young and older CRC patients without hereditary 
CRC or IBD.
The percentage of young-onset patients in our study popu-
lation was 16.7%, and this value is similar to that of a previous 
study conducted in Asia.14 Some reports have suggested that 
young-onset and right-sided colon cancer is more common in 
males, but our study population showed a significant male 
predominance in older patients, with no difference in tumor 
location. Higher proportions of poor differentiation or mucinous 
pathology and lymphovascular invasion in the young patients 
were also consistent with the findings of previous studies.19,20 As 
mentioned above, NCCN guideline suggests more frequent 
surveillance colonoscopy in young age patients.9 However, the 
timing and number of colonoscopic examinations did not show 
any differences between the age groups. This result suggested 
that there is a distinction between guideline and clinical practice. 
In the first surveillance colonoscopy, the positive rates of 
adenoma, advanced neoplasia, and metachronous cancer were 
25.5%, 3.0%, and 0%. These findings are similar to the previous 
study results in which 3.2% of patients developed advanced 
adenoma and none had newly developed cancer 1 year after 
undergoing CRC resection.21,22 Overall surveillance colonoscopy 
results comparing age groups revealed that the positive rates of 
metachronous adenoma, advanced adenoma, and high-risk 
colonoscopic findings were significantly higher in the older age 
group. Our results were consistent with the suggestion in the 
previous studies that older age is a common risk factor for the 
development of metachronous advanced adenoma in survei-
llance colonoscopy after CRC resection.10,21,23,24
The identification of high-risk patients who require intensive 
surveillance colonoscopy is a critical issue, and several studies 
have suggested various risk factors such as aging, synchronous 
advanced neoplasia, male sex, tumor location, and history of 
diabetes.21,24 In the present study, older age, first-degree family 
history of CRC, and high-risk colonoscopic findings at index 
colonoscopy were associated with the development of meta-
chronous advanced neoplasia in univariate analysis. Young 
patients were definitely at lower risk compared to older patients 
according to the univariate and multivariate analysis. We also 
divided patients according to two significant factors in the 
univariate analysis to more selectively define patients at low risk 
for the development of metachronous advanced neoplasia. 
Patients without both family history of CRC and high-risk index 
colonoscopy findings showed a significantly lower risk for the 
development of metachronous advanced neoplasia. Moreover, 
none of the young patients in our study without these two risk 
factors developed metachronous advanced neoplasia. In our 
experience, young patients had a low probability of developing 
metachronous advanced neoplasia, especially those with no 
family history of CRC and low-risk index colonoscopy findings. As 
a result, the benefits of an intensive surveillance colonoscopy 
strategy in this patient group have a relatively low impact on the 
detection and prevention of metachronous advanced neoplasia. 
As a limitation of our study, the timing of surveillance 
colonoscopy was not equal in all patients, because of the inherent 
retrospective design of the study. However, we restricted the 
inclusion criteria to patients with the first surveillance 
colonoscopy within 2 years after surgery. In addition, in both age 
groups, the number and intervals of follow-up colonoscopies did 
not differ significantly. 
In conclusion, the present study showed that age is inde-
pendent factor for the development of metachronous advanced 
neoplasia after surgery compared to older onset patients. In 
particular, young patients without a family history of CRC and 
high-risk index colonoscopy findings have an extremely low rate 
of metachronous advanced neoplasia. Therefore, colonoscopy 
surveillance strategy should be adjusted with independent risk 
factors, including age and family history of CRC. 
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